National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 43551-43552 [2017-19731]
Download as PDF
<![CDATA[
sradovich on DSKBBY8HB2PROD with NOTICES
Federal Register / Vol. 82, No. 179 / Monday, September 18, 2017 / Notices
MSC 7808, Bethesda, MD 20892, 301–402–
5671, zhengli@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group;
Genomics, Computational Biology and
Technology Study Section.
Date: October 11–12, 2017.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crystal Gateway Marriott, 1700
Jefferson Davis Highway, Arlington, VA
22202.
Contact Person: Baishali Maskeri, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–827–2864, maskerib@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; SBIB
Clinical Pediatric and Fetal Applications
Subcommittee.
Date: October 11, 2017.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Songtao Liu, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
Bethesda, MD 20817, 301–435–3578,
songtao.liu@nih.gov.
Name of Committee: Cell Biology
Integrated Review Group; Molecular and
Integrative Signal Transduction Study
Section.
Date: October 11, 2017.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Charles Selden, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Room 5187
MSC 7840, Bethesda, MD 20892, 301–451–
3388, seldens@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Societal and
Ethical Issues in Research.
Date: October 11, 2017.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Karin F. Helmers, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3148,
MSC 7770, Bethesda, MD 20892, (301) 254–
9975, helmersk@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
VerDate Sep<11>2014
16:54 Sep 15, 2017
Jkt 241001
Dated: September 12, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–19728 Filed 9–15–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the NHLBI Special Emphasis
Panel.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Sex Hormone Induced Thromboembolism in
Pre-Menopausal Women.
Date: October 11, 2017.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Kristen Page, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6701 Rockledge Drive, Room 7185, Bethesda,
MD 20892, 301–827–7953, kristen.page@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: September 12, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–19729 Filed 9–15–17; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
43551
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; DDK–C Conflicts.
Date: October 13, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Jian Yang, Ph.D., Scientific
Review Officer, Review Branch, DEA,
NIDDK, National Institutes of Health, Room
7111, 6707 Democracy Boulevard, Bethesda,
MD 20892–5452, (301) 594–7799, yangj@
extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; PAR–16–034:
Ancillary Studies in Kidney Disease (R01).
Date: October 25, 2017.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Ann A. Jerkins, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7119, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, 301–594–2242,
jerkinsa@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
E:\FR\FM\18SEN1.SGM
18SEN1
43552
Federal Register / Vol. 82, No. 179 / Monday, September 18, 2017 / Notices
Dated: September 12, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–19731 Filed 9–15–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
sradovich on DSKBBY8HB2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Kidney, Urologic and
Hematologic Diseases D Subcommittee.
Date: October 17–19, 2017.
Time: 4:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Barbara A. Woynarowska,
Ph.D., Scientific Review Administrator,
Review Branch, DEA, NIDDK, National
Institutes of Health, Room 7007, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 402–7172, woynarowskab@
niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Digestive Diseases and
Nutrition C Subcommittee.
Date: October 18–20, 2017.
Time: 5:45 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Maria E. Davila-Bloom,
Ph.D., Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 7017, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7637, davila-bloomm@
extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Diabetes,
VerDate Sep<11>2014
16:54 Sep 15, 2017
Jkt 241001
Endocrinology and Metabolic Diseases B
Subcommittee.
Date: October 25–27, 2017.
Time: 5:30 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Capital View, 2850
South Potomac Avenue, Arlington, VA
22202.
Contact Person: John F. Connaughton,
Ph.D., Chief, Scientific Review Branch,
Review Branch, DEA, NIDDK, National
Institutes Of Health, Room 7007, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 594–7797, connaughtonj@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: September 12, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–19730 Filed 9–15–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2010–0164]
National Boating Safety Advisory
Council
U.S. Coast Guard, Department
of Homeland Security.
ACTION: Notice of Federal Advisory
Committee meeting.
AGENCY:
The National Boating Safety
Advisory Council and its
Subcommittees will meet to discuss
issues relating to recreational boating
safety. These meetings will be open to
the public.
DATES: The National Boating Safety
Advisory Council will meet on Tuesday,
October 10, 2017, from 8 a.m. to 11:30
a.m. and Thursday, October 12, 2017
from 9 a.m. to 12:00 p.m. The Boats and
Associated Equipment Subcommittee
will meet on Tuesday, October 10, 2017,
from 1 p.m. to 2:30 p.m. The Prevention
through People Subcommittee will meet
on Tuesday, October 10, 2017, from 2:45
p.m. to 5 p.m. The Recreational Boating
Safety Strategic Planning Subcommittee
will meet on Wednesday, October 11,
2017, from 8:30 a.m. to 10 a.m. The
Regulatory Reform Review
Subcommittee will meet on Wednesday,
October 11, 2017 from 10:15 a.m. to
11:30 a.m. and 1 p.m. to 5 p.m. Please
note that these meetings may conclude
SUMMARY:
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
early if the National Boating Safety
Advisory Council has completed all
business.
ADDRESSES: All meetings will be held in
the Ballroom of the Holiday Inn
Arlington (https://www.hiarlington.com),
4610 N. Fairfax Drive, Arlington, VA
22203.
For information on facilities or
services for individuals with disabilities
or to request special assistance at the
meeting, contact the individual listed in
the FOR FURTHER INFORMATION CONTACT
section below as soon as possible.
Instructions: You are free to submit
comments at any time, including orally
at the meetings, but if you want Council
members to review your comment
before the meetings, please submit your
comments no later than October 2, 2017.
We are particularly interested in the
comments in the ‘‘Agenda’’ section
below. You must include ‘‘Department
of Homeland Security’’ and the docket
number USCG–2010–0164. Written
comments may also be submitted using
the Federal eRulemaking Portal at
https://www.regulations.gov. If you
encounter technical difficulties with
comments submission, contact the
individual listed in the FOR FURTHER
INFORMATION CONTACT section below.
Comments received will be posted
without alteration at https://
www.regulations.gov, including any
personal information provided. You
may review the Privacy and Security
Notice for Regulations.gov at https://
www.regulations.gov/privacyNotice.
Docket Search: For access to the
docket to read documents or comments
related to this notice, go to https://
www.regulations.gov insert USCG–
2010–0164 in the ‘‘Search’’ box, press
Enter, then click the item you wish to
view.
FOR FURTHER INFORMATION CONTACT: Mr.
Jeff Ludwig, Alternate Designated
Federal Officer of the National Boating
Safety Advisory Council, telephone
(202) 372–1061, or at jeffrey.a.ludwig@
uscg.mil.
SUPPLEMENTARY INFORMATION: Notice of
this meeting is given pursuant to the
Federal Advisory Committee Act (Title
5, U.S.C, Appendix). Congress
established the National Boating Safety
Advisory Council in the Federal Boat
Safety Act of 1971 (Pub. L. 92–75). The
National Boating Safety Advisory
Council currently operates under the
authority of 46 U.S.C. 13110 and 46
U.S.C. 4302(c). The latter requires the
Secretary of Homeland Security and the
Commandant of the U.S. Coast Guard by
delegation to consult with the National
Boating Safety Advisory Council in
prescribing regulations for recreational
E:\FR\FM\18SEN1.SGM
18SEN1
]]>Agencies
[Federal Register Volume 82, Number 179 (Monday, September 18, 2017)]
[Notices]
[Pages 43551-43552]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-19731]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; DDK-C Conflicts.
Date: October 13, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Jian Yang, Ph.D., Scientific Review Officer,
Review Branch, DEA, NIDDK, National Institutes of Health, Room 7111,
6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-7799,
yangj@extra.niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; PAR-16-034: Ancillary
Studies in Kidney Disease (R01).
Date: October 25, 2017.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Ann A. Jerkins, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7119, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 301-
594-2242, jerkinsa@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
[[Page 43552]]
Dated: September 12, 2017.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-19731 Filed 9-15-17; 8:45 am]
BILLING CODE 4140-01-P
